RainDance Technologies’ Customers to Showcase Cancer Research Successes at Advances in Genome Biology and Technology Meeting
Published: Feb 15, 2012
LEXINGTON, Mass. & MARCO ISLAND, Fla.--(BUSINESS WIRE)--RainDance Technologies, Inc., the Digital Biology™ Company, and customers including the National Cancer Institute (NCI), British Columbia Cancer Agency (BCCA), and Asuragen will highlight recent successes with RainDance’s advanced targeted sequencing solutions for cancer research at this year’s Advances in Genome Biology and Technology (AGBT) meeting. RainDance is also a sponsor and presenter at AGBT which is taking place in Marco Island, Florida from February 15-18.